The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells

EMBO Journal

Volumn 17, Issue 16, 1998, Pages 4594-4605

  Grütz, Gerald G ^a   Bucher, Katharina ^a   Lavenir, Isabelle ^a   Larson, Tammy ^b   Larson, Rodney ^c   Rabbitts, Terence H ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Chromosomal translocation; Leukaemia; LIM; LMO2; TAL1

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA BINDING PROTEIN; ONCOPROTEIN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; ERYTHROID CELL; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE; TRANSGENIC ANIMAL;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA-BINDING PROTEINS; IMMUNE SERA; LYMPHOMA, T-CELL; METALLOPROTEINS; MICE; MICE, TRANSGENIC; OLIGODEOXYRIBONUCLEOTIDES; SEQUENCE HOMOLOGY, NUCLEIC ACID; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

ANIMALIA; MUS MUSCULUS;

EID: 0032541488     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.16.4594     Document Type: Article

References (51)

1. Agulnick, A.D., Taira, M., Breen, J.J., Tanaka, T., Dawid, I.B. and Westphal, H. (1996) Functional and physical interaction of Ldb1, a novel LIM domain binding factor, with the LIM homeodomain protein Lhx1/Xlim-1. Nature, 384, 270-272.
2. Bain, G. et al. (1997) E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol., 17, 4782-4791.
3. Boehm, T., Foroni, L., Kaneko, Y., Perutz, M.P. and Rabbitts, T.H. (1991a) The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc. Natl Acad. Sci. USA, 88, 4367-4371.
4. Boehm, T., Spillantini, M.-G., Sofroniew, M.V., Surani, M.A. and Rabbitts. T.H. (1991b) Developmentally regulated and tissue-specific expression of mRNAs encoding the two alternative forms of the LIM domain oncogene rhombotin: evidence for thymus expression. Oncogene, 6, 695-703.
5. Cheng, J.T., Hsu, H.-L., Hwang, L.-Y. and Baer, R. (1993) Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues. Oncogene, 8, 667-683.
6. Condorelli, G.L., Facchiano, F., Valtieri, M., Proietti, E., Vitelli, L., Lulli, V., Huebner, K., Peschle, C. and Croce, C.M. (1996) T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. Cancer Res., 56, 5113-5119.
7. Fehling, H.J. and von Boehmer,H. (1997) Early αβ T cell development in the thymus of normal and genetically altered mice. Curr. Opin. Immunol., 9, 263-275.
8. Fisch, P., Boehm, T., Lavenir, I., Larson, T., Arno, J., Forster, A. and Rabbitts, T.H. (1992) T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes. Oncogene, 7, 2389-2397.
9. Foroni, L. et al. (1992) The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development. J. Mol. Biol., 226, 747-761.
10. Hsu, H.-L., Huang, L., Tsan, J.T., Funk, W., Wright, W.E., Hu, J.-S., Kingston, R.E. and Baer, R. (1994a) Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol. Cell. Biol., 14, 1256-1265.
11. Hsu, H.-L., Wadman, T. and Baer, R. (1994b) Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells. Proc. Natl Acad. Sci. USA, 91, 3181-3185.
12. Hsu, H.-L., Wadman, I., Tsan, J.T. and Baer, R. (1994c) Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc. Natl Acad. Sci. USA, 91, 5947-5951.
13. Jurata, L.W., Kenny, D.A. and Gil, G.N. (1996) Nuclear LIM interactor, a rhombotin and LIM homeodomain interacting protein, is expressed early in neuronal development. Proc. Natl Acad, Sci. USA, 93, 11693-11698.
14. Jurata, L.W., Pfaff, S.L. and Gill, G.N. (1998) The nuclear LIM domain interactor NL1 mediates homo- and heterodimerization of LIM domain transcription factors. J. Biol. Chem., 273, 3152-3157.
15. Kallianpur, A.R., Jordan, J.E. and Brandt, S.J. (1994) The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood, 85, 1200-1208.
16. Kelliher, M.A., Seldin, D.C. and Leder, P. (1996) Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIα. EMBO J., 15, 5160-5166.
17. Lang, G., Wotton, D., Owen, M.J., Sewell, W.A., Brown, M.H., Mason.D.Y., Crumpton, M.J. and Kioussis, D. (1988) The structure of the human CD2 gene and its expression in transgenic mice. EMBO J., 7, 1675-1682.
18. Larson, R., Fisch, P., Larson, T., Lavenir, I., Langford, T., King, G. and Rabbitts, T.H. (1994) T cell tumours with disparate phenotypes develop with long latency in mice transgenic for rbtn2. Oncogene, 9, 3675-3681.
19. Larson, R.C., Osada, H., Larson, T.A., Lavenir, I. and Rabbitts, T.H. (1995) The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice. Oncogene, 11, 853-862.
20. Larson, R.C., Lavenir, I., Larson, T.A., Baer, R., Warren, A.J., Wadman, I., Nottage, K. and Rabbitts, T.H. (1996) Protein dimerisation between Lmo2 (Rbtn2) and Tall alters thyrnocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J., 15, 1021-1027.
21. LeFranc, M.-P., Forster, A., Baer, R., Stinson, M.A. and Rabbitts, T.H. (1986) Diversity and rearrangement of the human T cell rearranging γ genes: nine germ-line variable genes belonging to two subgroups. Cell, 45, 237-246.
22. Malissen, M. et al. (1984) Mouse T cell antigen receptor: structure and organization of constant and joining gene segments encoding the β polypeptide. Cell, 37, 1101-1110.
23. McGuire, E.A., Rintoul, C.E., Sclar, G.M. and Korsmeyer, S.J. (1992) Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma. Mol. Cell. Biol., 12, 4186-4196.
24. Miyamoto, A., Cui, X., Naumovski, L. and Cleary, M.L. (1996) Helixloop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells, Mol. Cell. Biol., 16, 2394-2401.
25. Mizushima, S. and Nagata, S. (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res., 18, 5322.
26. Murre, C., McCaw, P.S. and Baltimore, D. (1989) A new DNA binding and dimerisation motif in immunoglobulin enhancer binding, daughterless, MyoD and myc proteins. Cell, 56, 777-783.
27. Neale, G.A., Rehg, J.E. and Goorha, R.M. (1995) Ectopic expression of rhombotin-2 causes selective expansion of the thymus and T-cell tumours in transgenic mice. Blood, 86, 3060-3071.
28. Ono, Y., Fukuhara, N. and Yoshie, O. (1997) Transcriptional activity of TAL1 in the T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL. J. Biol. Chem., 272, 4576-4581.
29. Osada, H., Grutz, G., Axelson, H., Forster, A. and Rabbitts, T.H. (1995) Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1. Proc. Natl Acad. Sci, USA, 92, 9585-9589.
30. Pevny, L., Simon, M.C., Robertson, E., Klein, W.H., Tsai, S.-R., D'Agati, V., Orkin, S.H. and Costantini, F. (1991) Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature, 349, 257-260.
31. Pollock, R. and Treisman, R. (1990) A sensitive method for the determination of protein-DNA binding specificities. Nucleic Acids Res., 18, 6197-6204.
32. Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F.W. and Orkin, S.H. (1996) The T cell leukemia oncoprotein SCl/tal-1 is essential for development of all hematopoietic lineages. Cell, 86, 47-57.
33. Pulford, K., Lecointe, N., Leroy-Viard, E.L., Jones, M., Mathieu-Mahul, D. and Mason, D.Y. (1995) Expression of TAL-1 proteins in human tissues. Blood, 85, 675-684.
34. Rabbitts, T.H. (1994) Chromosomal translocations in human cancer. Nature, 372, 143-149.
35. Rabbitts, T.H., Forster.A., Larson, R. and Nathan, P. (1993) Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nature Genet., 4, 175-180.
36. Robb, L., Lyons, I., Li.R., Hartley.L., Kontgen, F., Harvey, R.P., Metcalf, D. and Begley, C.G. (1995a) Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl Acad. Sci. USA, 92, 7075-7079.
37. Robb, L., Rasko, J.E.J., Bath, M.L., Strasser, A. and Begley, C.G. (1995b) scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice. Oncogene, 10, 205-209.
38. Robb, L., Elwood, N.J., Elefanty, A.G., Kontgen, F., Li, R., Barnet, L.D. and Begley, C.G. (1996) The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J., 15, 4123-4129.
39. Roberts, V.J., Steenbergen, R. and Murre, C. (1993) Localization of E2A mRNA expression in developing and adult rat tissues. Proc. Natl Acad. Sci. USA, 90, 7583-7587.
40. Royer-Pokora, B., Loos, U. and Ludwig, W.-D. (1991) TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t (11;14) (p13;q11). Oncogene, 6, 1887-1893.
41. Shivdasani, R.A., Mayer, E. and Orkin, S.H. (1995) Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature, 373, 432-434.
42. Shivdasani, R.A., Fujiwara, Y., McDevitt, M.A. and Orkin, S.H. (1997) A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development, EMBO J., 16, 3965-3973.
43. Sun, X.-H. and Baltimore, D. (1991) An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell, 64, 459-470.
44. Valge-Archer, V.E., Osada, H., Warren, A.J., Forster, A., Li, J., Baer, R. and Rabbitts, T.H. (1994) The LIM protein RBTN2 and the bHLH protein TAL1 are present in a complex in erythroid cells. Proc. Natl Acad. Sci. USA, 91, 8617-8621.
45. Visvader, J.E., Mao, X., Fujiwara, Y., Hahm, K. and Orkin, S.H. (1997) The LIM-domain binding protein Ldb1 and its partner LM02 act as negative regulators of erythroid differentiation. Proc. Natl Acad. Sci. USA, 94, 13707-13712.
46. Wadman, I., Li, J., Bash, R.O., Forster, A., Osada, H., Rabbitts, T.H. and Baer, R. (1994) Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukaemia. EMBO J., 13, 4831-4839.
47. Wadman, I.A., Osada, H., Grutz, G.G., Agulnick, A.D., Westphal, H., Forster, A. and Rabbitts, T.H. (1997) The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J., 16, 3145-3157.
48. Warren, AJ., Colledge, W.H., Carlton, M.B.L., Evans, M.J., Smith, A.J.H. and Rabbitts, T.H. (1994) The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell, 78, 45-58.
49. Wright, W.E., Binder, M. and Funk, W. (1991) Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site, Mol. Cell. Biol., 11, 4104-4110.
50. Yamada, Y., Warren, A.W., Dobson, C., Forster, A., Pannell, R. and Rubbitts, T.H. (1998) The T cell leukaemia LIM protein Lmo2 is necessary for adult mouse haematopoiesis. Proc. Natl Acad. Sci. USA, 95, 3890-3895.
51. Yan, W., Young, A.Z., Soares, V.C., Kelley, R., Benezra, R. and Zhuang, Y. (1997) High incidence of T-cell tumors in E2A-null mice and E2A/ Id1 double-knockout mice. Mol. Cell. Biol., 17, 7317-7327.